Sep 11, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study
PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.
Aug 27, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment
Pulse Biosciences shares rise on first-in-human study showing its nsPFA tech cuts thyroid nodule size with strong safety and efficacy.
Aug 13, 2025 • Motley Fool
SOMEWHAT-BULLISH
Pulse Biosciences Cash Jumps in Q2
Pulse Biosciences ( NASDAQ:PLSE ) , a medical device innovator focused on nanosecond pulsed field ablation ( nsPFA ) for treating various conditions, released its second-quarter 2025 results on August 12, 2025. The company reported another pre-commercial quarter, with no revenue.
Apr 09, 2025 • Benzinga
SOMEWHAT-BULLISH
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors - Corvus Pharma ( NASDAQ:CRVS )
SOUTH SAN FRANCISCO, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- Corvus Pharmaceuticals, Inc. CRVS, a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at HSMR Advisors, has been appointed to the Company's board of directors.
Aug 13, 2024 • Benzinga
BULLISH
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday - Loar Holdings ( NYSE:LOAR )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Tuesday. Shares of Loar Holdings Inc. LOAR rose sharply during Tuesday's session after the company reported better-than-expected second-quarter GAAP EPS and sales.
Jul 11, 2024 • Stocknews.com
BULLISH
Pulse Biosciences ( NASDAQ:PLSE ) Stock Rating Upgraded by StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Free Report ) was upgraded by stock analysts at StockNews.com to a "sell" rating in a research note issued on Thursday. NASDAQ:PLSE opened at $14.86 on Thursday. Pulse Biosciences has a twelve month low of $3.78 and a twelve month high of $17.05.